Breaking News
December 14, 2018 - Scientists perform lung lavage as new approach for tuberculosis diagnosis in rhinoceros
December 14, 2018 - Recent winners of the Nobel Medicine Prize
December 14, 2018 - KHN’s ‘What the Health?’ Insurance enrollment is lagging — and there are lots of reasons why
December 14, 2018 - Study assesses safety and efficacy of new treatment for pancreatic cancer
December 14, 2018 - Study finds drug targets for Ebola, Dengue, and Zika viruses
December 14, 2018 - Study highlights need for personalized approach to treat ICU acquired delirium
December 14, 2018 - Massage helps relieve pain, improve mobility in patients with knee osteoarthritis
December 14, 2018 - Average outpatient visit in the U.S. costs nearly $500, shows new study
December 14, 2018 - Reference Infliximab, Biosimilar Equivalent for Crohn’s Disease
December 14, 2018 - New contact lens to treat eye injuries
December 14, 2018 - Acne could have a genetic basis find researchers promising new cure
December 14, 2018 - Higher physical activity associated with improved mood
December 14, 2018 - New UGA study points to optimal hypertension treatment for stroke patients
December 14, 2018 - Study highlights factors that can reduce food cravings
December 14, 2018 - Researchers discover Ebola-fighting protein in human cells
December 14, 2018 - Fentanyl surpasses heroin in cause of U.S. drug overdose deaths
December 14, 2018 - When Heart Attack Strikes, Women Often Hesitate to Call for Help
December 14, 2018 - A warning about costume contacts
December 14, 2018 - Study examines link between peripheral artery disease and heart attack
December 14, 2018 - Researchers develop biotechnological tool to produce antifungal proteins in plants
December 14, 2018 - 3D-printed adaptive aids can benefit patients with arthritis
December 14, 2018 - Chronic bullying during adolescence impacts mental health
December 14, 2018 - Integral Molecular and Merus collaborate to develop bispecific antibody therapeutics
December 13, 2018 - Importance of cell cycle and cellular senescence in the placenta discovered
December 13, 2018 - Gold “nanoprisms” open new window into vessels and single cells
December 13, 2018 - Research findings could lead to new targets for cancer-fighting therapeutics
December 13, 2018 - Butantan Institute signs collaboration agreement with MSD to develop dengue vaccines
December 13, 2018 - Study explores how patients want to discuss symptoms with doctors
December 13, 2018 - RUDN medics first to gather scattered data on hepatitis morbidity in Somalia
December 13, 2018 - Age and gender disparities found in use of bed nets to prevent malaria in sub-Saharan Africa
December 13, 2018 - Caffeine therapy benefits developing brains of premature babies
December 13, 2018 - New review focuses on electrospinning techniques used in musculoskeletal tissue engineering
December 13, 2018 - A new division focused on human immune system
December 13, 2018 - Zogenix Announces Positive Phase 3 Trial Results on the Efficacy and Safety of Fintepla (ZX008) in Dravet Syndrome
December 13, 2018 - BCR ABL Genetic Test: MedlinePlus Lab Test Information
December 13, 2018 - Caffeinated beverages during pregnancy linked to lower birth weight babies
December 13, 2018 - Stanford Medicine Health Trends Report examines opportunity to democratize health care
December 13, 2018 - Obsessive-compulsive disorder may protect individuals from obesity
December 13, 2018 - Scientists investigate how a painful event is processed in the brain
December 13, 2018 - Genetic study reveals new insights into underlying causes of moderate-to-severe asthma
December 13, 2018 - Study uncovers new genetic clues to frontotemporal dementia
December 13, 2018 - Vitamin C supplementation for pregnant smokers may reduce harm to infants’ lungs
December 13, 2018 - New study reveals yin-yang personality of dopamine
December 13, 2018 - Research identifies nerve-signaling pathway behind sustained pain after injury
December 13, 2018 - Children with high levels of callous traits show widespread differences in brain structure
December 13, 2018 - Long-term Benefit of Steroid Injections for Knee Osteoarthritis Challenged
December 13, 2018 - Adding new channels to the brain remote control
December 13, 2018 - In the Spotlight: A different side of neuroscience
December 13, 2018 - Medical Marvels: Using immunotherapy for melanoma that spread to the brain
December 13, 2018 - Puzzles do not keep dementia away finds study
December 13, 2018 - New mouse model shows potential for rapid identification of promising muscular dystrophy therapies
December 13, 2018 - Study reveals urban and rural differences in prenatal exposure to essential and toxic elements
December 13, 2018 - New collaborative partnership in quest of novel antibiotics
December 13, 2018 - Single tau molecule holds clues to help diagnose neurodegeneration in its earliest stages
December 13, 2018 - AHA Scientific Statement: Low Risk of Side Effects for Statins
December 13, 2018 - What Is Acute Flaccid Myelitis?
December 13, 2018 - How bereaved people control their thoughts without knowing it
December 13, 2018 - Health care democratization underway, according to 2nd annual Stanford Medicine Health Trends Report | News Center
December 13, 2018 - Going Beyond a Single Color
December 13, 2018 - London-based startup launches ‘thedrug.store’ aiming to clean up CBD industry
December 13, 2018 - Loss of tight junction barrier protein results in gastric cancer development
December 13, 2018 - Novel way to efficiently deliver anti-parasitic medicines
December 13, 2018 - RKI publishes new data on disease prevention and utilization of medical services
December 13, 2018 - High-tech, flexible patches sewn into clothes could help to stay warm
December 13, 2018 - The CCA releases three reports on requests for medical assistance in dying
December 13, 2018 - Restoring Hair Growth on Scarred Skin? Mouse Study Could Show the Way
December 13, 2018 - Probiotic use may reduce antibiotic prescriptions, researchers say
December 13, 2018 - Drug repositioning strategy identifies potential new treatments for epilepsy
December 13, 2018 - Chronic rhinitis associated with hospital readmissions for asthma and COPD patients
December 13, 2018 - Food poisoning discovery could save lives
December 13, 2018 - Cloned antibodies show potential to treat, diagnose life-threatening fungal infections
December 13, 2018 - Exercise may reduce colorectal cancer risk after weight loss
December 13, 2018 - Russian scientists create hardware-information system for brain disorders treatment
December 13, 2018 - Moderate alcohol consumption linked with lower risk of hospitalization
December 13, 2018 - Nurturing Healthy Neighborhoods | NIH News in Health
December 13, 2018 - Rise in meth and opioid use during pregnancy
December 13, 2018 - Researchers gain new insights into pediatric tumors
December 13, 2018 - FSU study finds racial disparity among adolescents receiving flu vaccine
December 13, 2018 - Study investigates attitudes toward implementation of ‘sex as a biological variable’ policy
December 13, 2018 - Drug cocktail induces cancer cell death by switching off energy supply
BRAF Mutation Status Tied to Papillary Thyroid Cancer Mortality

BRAF Mutation Status Tied to Papillary Thyroid Cancer Mortality

image_pdfDownload PDFimage_print

Action Points

  • Note that this observational study found that older age is a risk factor for aggressive papillary thyroid cancer, but only among those with BRAF V600E mutations.
  • With further confirmation, this may allow older individuals with wild-type BRAF thyroid cancer to avoid some of the most toxic therapies.

While age is a strong, and independent, mortality risk factor in papillary thyroid cancer (PTC) patients with BRAF V600E mutation, that is not the case in patients with wild-type BRAF, investigators have found in a retrospective study.

This finding challenges the long-held belief that the general use of patient age at diagnosis is a high-risk factor in PTC.

These findings were from a comparative study led by Xiaopei Shen, PhD, Johns Hopkins University School of Medicine in Baltimore, and published in the Journal of Clinical Oncology.

PTC is the most common type of thyroid cancer, accounting for >85% of all thyroid malignancies. As pointed out by Shen and his colleagues, risk stratification — based on clinicopathologic risk factors such as patient age — is an important component of standard management of thyroid cancer.

In fact, use of age as a major risk factor in thyroid cancer has been accepted since 1953, when a study in Annals of Surgery made the connection. And other studies have suggested that mortality in thyroid cancer goes up with increasing patient age.

“However, critical questions remain unanswered as to why older patient age has such a remarkable adverse effect on PTC-specific mortality and whether age is a risk factor universally applicable to all patients with PTC,” Shen and his colleagues wrote.

The investigators noted that the BRAF V600E mutation is known to be a main driver of PTC and is associated with older patient age and poor clinical outcomes. With this in mind they hypothesized that not only does BRAF V600E play an important role in the effect of patient age on PTC-specific mortality, but that in the absence of that mutation age may not be a risk factor.

To test that hypothesis Shen and his colleagues compared data on 2,638 patients (623 men and 2,015 women) with PTC from 11 medical centers in six countries. Patients had a median age of 46 (interquartile range 35-58), and a median follow-up of 58 months (IQR 26-107 months).

Shen and his colleagues found that after the age of 45 mortality rates increased as patient age increased overall — but the subgroup analysis by BRAF V600E mutation status showed the increase was entirely confined to those with the mutation.

And after adjusting for sex, tumor size, extrathyroidal extension, lymph node metastasis, distant metastasis, and administered activities of radioactive iodine, the linear relationship between PTC mortality and BRAF V600E remained, but was not seen in patients with wild-type BRAF.

These findings should have a major impact on the clinical management of PTC, the investigators suggested, considering the prevalence of BRAF V600E mutation in PTC is about 45%.

“As such, many older patients will be able to avoid more aggressive treatment that would otherwise be administered as a result of the conventional concept of older patient age being a general high-risk factor,” Shen and his colleagues wrote.

In an editorial accompanying the study, Megan Haymart, MD, of the University of Michigan in Ann Arbor, said that while the study’s findings provide insight into the relationship between age and thyroid cancer prognosis, the study was limited by the fact the authors only studied the absence or presence of one mutation.

“A necessary next step is evaluating age-related prognostication and other molecular markers, including evaluating the relationship between age, death, and coexistence of BRAF V600E and TERT promoter mutations,” she wrote.

She also pointed out that this study focused solely on papillary thyroid cancer. While that is the most common type of differentiated thyroid cancer, she noted that follicular thyroid cancer and Hürthle cell cancer are also staged by age.

Further studies are needed to confirm the concept of designing distinct staging systems on the basis of BRAF, “and whether our future staging systems will incorporate a molecular-based approach to risk stratification remains to be determined,” Haymart concluded. “Yet, this is a worthy area of investigation that offers potential opportunities to further tailor prognostication through a better understanding of pathogenesis.”

Supported by National Institutes of Health (NIH) Grants No. R01CA113507 and R01CA189224 (M.X.); Polish National Center of Research and Development MILESTONE Project Grant No. STRATEGMED2/267398/4/NCBR/2015 (Poland, A.C., B.J.); grants from Menzies Health Institute, Griffith University, Queensland Cancer Council and Queensland Smart State Fellowship (Australia; A.K.L.); Grants No. SAF2013-44709-R and SAF2016-75531-R (MINECO and FEDER), RD12/0036/0030, PI14/01980 (ISCIII), and GCB14142311CRES (AECC Foundation) (Spain; P.S. and G.R-E); Grants No. AZV 16-32665A and MH CZ-DRO (Institute of Endocrinology-EU, 00023761; Czech Republic; B.B., V.S.); grants from the New South Wales Cancer Institute (C.J.O.) and Cancer Council of New South Wales (Australia; R.C.-B.); NIH/National Institute on Aging Grant No. 5R03AG042334-02 (L.Y.); and grants from the Ministero della Istruzione Universitaria e Ricerca Scientifica, the Associazione Italiana per la Ricerca sul Cancro, the Istituto Toscano Tumori, and the Ministero della Salute (Italy; D.V., R.E.).

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

1969-12-31T19:00:00-0500

last updated

Tagged with:

About author

Related Articles